These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17086147)

  • 21. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study.
    Steiner T; Bluhmki E; Kaste M; Toni D; Trouillas P; von Kummer R; Hacke W
    Cerebrovasc Dis; 1998; 8(4):198-203. PubMed ID: 9684058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage.
    Hassan AE; Hassanzadeh B; Tohidi V; Kirmani JF
    South Med J; 2010 May; 103(5):398-402. PubMed ID: 20375952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
    Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S
    Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry.
    Makihara N; Okada Y; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Hasegawa Y; Kario K; Okuda S; Naganuma M; Toyoda K
    Cerebrovasc Dis; 2012; 33(3):240-7. PubMed ID: 22261711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing outcome and recanalization results in patients with anterior circulation stroke following endovascular treatment with and without a treatment with rt-PA: A single-center study.
    Al-Khaled M; Brüning T; Gottwald C; Roessler F; Royl G; Eckey T
    Brain Behav; 2018 May; 8(5):e00974. PubMed ID: 29761023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
    JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
    Bhatia R; Hill MD; Shobha N; Menon B; Bal S; Kochar P; Watson T; Goyal M; Demchuk AM
    Stroke; 2010 Oct; 41(10):2254-8. PubMed ID: 20829513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
    Li YH; Li MH; Zhao JG; Wang W
    J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravenous thrombolysis with rt-PA in stroke: experience of the French military hospital of Toulon from September 2003 to June 2009].
    Faivre A; Sagui E; Canini F; Wybrecht D; Bounolleau P; Grapperon J; Alla P; Valance J
    Rev Neurol (Paris); 2010 Nov; 166(11):909-20. PubMed ID: 20452634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Interventional Management of Stroke (IMS) II Study.
    IMS II Trial Investigators
    Stroke; 2007 Jul; 38(7):2127-35. PubMed ID: 17525387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?
    Qureshi AI; Ezzeddine MA; Nasar A; Suri MF; Kirmani JF; Janjua N; Divani AA
    Neurology; 2006 Apr; 66(8):1171-4. PubMed ID: 16636232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.
    Grotta J;
    Cerebrovasc Dis; 2001; 12(3):258-63. PubMed ID: 11641593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are the results of intravenous thrombolysis trials reproduced in clinical practice? Comparison of observed and expected outcomes with the stroke-thrombolytic predictive instrument (STPI).
    Decourcelle A; Moulin S; Dequatre-Ponchelle N; Bodenant M; Rossi C; Girot M; Hénon H; Wiel E; Bordet R; Goldstein P; Pruvo JP; Cordonnier C; Leys D
    Rev Neurol (Paris); 2017 Jun; 173(6):381-387. PubMed ID: 28454980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of survival and hyperthermia after rt-PA for ischemic stroke.
    Ueno T; Nishijima H; Hikichi H; Haga R; Arai A; Suzuki C; Nunomura JI; Tomiyama M
    Acta Neurol Scand; 2018 Dec; 138(6):574-578. PubMed ID: 30091238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
    García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
    Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.